• xxx

FORUM 2017

Hilton Birmingham Metropole, 15th & 16th June 2017

Hilton Birmingham Metropole, Thursday 15th & Friday 16th June 2017

Welcome to the new UK Oncology Forum website! We hope that you like the new look and find the website useful.

This year sees the UK Oncology Forum expand its outreach to include other cancer organisations and cancer charities. Our mission statement is “Working TOGETHER, Working for Patients”.

We are proud to announce that we are offering FREE exhibition space to cancer charities that support our patients and vital research projects. We are the first UK national pan-tumour cancer meeting to provide a FREE platform to charities to give them the opportunity to share their initiatives and research projects with UK cancer healthcare professionals.

We have also offered free meeting facilities to our colleagues from other cancer organisations that support the continued educational needs of UK cancer healthcare professionals. We are delighted to announce that the ACP will hold their AGM on the morning of the 2017 UK Oncology Forum. This will result in a further 150 medical oncologists joining us on day one of the meeting and some will also stay for day two.

In addition to the ACP our colleagues from BOPA, UKONs, NCRI and UKOMIC will also be holding individual pre-Forum meetings and then go on to join us for the rest of the meeting.

We are thrilled to welcome Dr Sergio Quezada as the 2017 opening keynote speaker. Sergio will talk about his work into how and why some tumours respond to immunotherapies. Sergio has produced work looking at the mutational studies of tumours and why this might predict a response to immune-oncology drugs. We look forward with great interest to hearing about this important and relevant subject.

The whole faculty will join me in thanking Professor Thomas Helleday for taking time out of his very busy schedule to fly to Birmingham from the Karolinska Institutet, to be our closing keynote speaker.

Thomas will talk about “Targeting DNA repair in cancer treatments: towards affordable medicine?” Thomas will cover the clinical development of evolving number of DNA repair inhibitors and will also include a presentation of a new open innovation model for drug development and how this may influence the wider treatment of cancer.  We are delighted that he can join us.

In addition to the clinical streams, 2017 sees us split the Lung and Melanoma session into two separate clinical sessions. Dr Marianne Nicolson will continue to chair the Lung clinical session and Dr Paul Nathan has kindly agreed to chair the NEW Melanoma clinical stream.

Countdown to 2017 Forum event

We are delighted to welcome Dr Alison Jones as the new Chair for the Breast Cancer streams. We would like to thank Professor Paul Ellis for all his hard work of the past two years.

We also have a new chair for the Prostate Cancer clinical session, Dr Nicholas Van As from the Royal Marsden. Nick will take over from Professor Amit Bahl. We would like to welcome Nick to the UK Oncology Forum team and thank Amit for all his hard work as a former faculty member.

We always like to add a new and topical clinical stream to the meeting every year. This year we are adding a “Cancer Drug Toxicity” session that I will chair. We will have a team of experts discussing some of the challenges of the acute and chronic toxicities with cancer drugs, both old and new, and how these may best be managed.

As usual we will include the very important updates and breaking news from ASCO within all of the clinical sessions.

Of course the Oncology Forum would not be the Forum without the very popular Question Time Session, chaired by broadcaster Peter Sissons! As always this will be as provocative and lively as ever, with a distinguished and dynamic panel. More details to follow...

With the 2017 Oncology Forum expanding and becoming much more collaborative it promises to be stimulating, interactive and as provocative as ever! Of course none of this would be possible without the ongoing and unwavering support of the Faculty, the input and commitment of all the session chairs and speakers, your time and engagement in the sessions and last, but not least, the generous non-restricted educational grants from industry.

We would like to especially thank Healthcare at Home and all our other supporters for their commitment to this special UK educational meeting. The Faculty, session chairs and myself look forward to welcoming you to Birmingham and to meeting you all personally. If any companies are interested in being part of the 2017 meeting, please contact Sharon Poole directly sharon@athenameetings.com

Please continue to visit our new website to keep updated on the progress of the 2017 UK Oncology Forum programme. I look forward to welcoming you to Birmingham in June.

Kind regards

Professor Ruth Plummer
Clinical Professor of Experimental Cancer Medicine, Northern Institute for Cancer Research, Newcastle University
Chair UK Oncology Forum


UKOMIC & EOCC Joint Committee Meeting (special invitation – members only)
UKONS ‘Introducing the impact of immunotherapies – adapting the toolkit and developing good practice guidance in the empowerment and proactive monitoring of patients.’ (Special invitation only - strictly UKONs members only)
10:00 - 12:00 NCRi Anorectal Subgroup Committee meeting (special invitation – members only)
10:15- 12:00 BOPA Committee Meeting (special invitation - strictly BOPA members only)
10:30 - 12:00 The Association of Cancer Physicians (ACP)
Annual General Meeting (special invitation only - strictly ACP members only)
EASI-SWITCH Investigator meeting (special invitation only)
Arrival, registration, buffet lunch, exhibition and
Cancer Charity Corner 8
Welcome and
Opening Keynote Speaker
Dr Sergio A Quezada PH.D
‘Mobilising Immunity to Fight Cancer’ 
14:30 - 14:25 Coffee & Exhibition
14:30 Clinical Sessions x 9 (see programme)
Question Time
Meeting concludes
20:00 Conference dinner (meet in exhibition area from 19:30hrs for networking)

FRIDAY 16th JUNE 2017

08:30 Main plenary
08:45 Clinical Sessions x 9
(see programme)
10:00 - 11:00 WORKSHOP - De-mystifying the science behind cancer immunotherapy (optional complimentary workshop for our industry colleagues) -
Dr Elaine Vickers
11:45 Clinical Sessions (Day 2) close
12:00 Closing Keynote Speaker
Professor Thomas Helleday
The concept of targeting DNA repair for cancer treatment will be described, and description of how mutations in DNA repair pathways can guide responding patient populations. Recent advances in pre-Clinical and Clinical development of evolving DNA repair inhibitors will be covered along with presentation of a new open innovation model for drug development and how this may influence wider treatment of cancer. 
13:00 Lunch & Exhibition
13:30 - 14:30 WORKSHOP - De-mystifying the science behind cancer immunotherapy (optional complimentary workshop for HCP's) - Dr Elaine Vickers
13:30  (onwards) Departures

Conference Schedule


National Exhibition Centre
B40 1PP